| human | Q5 |
| P496 | ORCID iD | 0000-0002-8895-935X |
| P11597 | Padua Research Archive author ID | 11881 |
| P1343 | described by source | BEIC Digital Library | Q51955019 |
| P108 | employer | University of Padua | Q193510 |
| P734 | family name | Rigotti | Q28404140 |
| Rigotti | Q28404140 | ||
| Rigotti | Q28404140 | ||
| P735 | given name | Paolo | Q15731774 |
| Paolo | Q15731774 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q38587188 | "Why can't I give you my organs after my heart has stopped beating?" An overview of the main clinical, organisational, ethical and legal issues concerning organ donation after circulatory death in Italy. |
| Q79444349 | 12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients |
| Q44967968 | A comparative prospective study of two available solutions for kidney and liver preservation |
| Q46985685 | A randomized exploratory trial of steroid avoidance in renal transplant patients treated with everolimus and low-dose cyclosporine. |
| Q56972164 | A randomized trial of everolimus and low-dose cyclosporine in renal transplantation: with or without steroids? |
| Q46452704 | A randomized trial of steroid avoidance in renal transplant patients treated with everolimus and cyclosporine. |
| Q85722190 | A single-center experience with 200 dual kidney transplantations |
| Q37211126 | ABCB1 genotypes predict cyclosporine-related adverse events and kidney allograft outcome |
| Q44101504 | Acute rejection after renal transplantation with tacrolimus-based therapy in conditions of normal clinical practice. |
| Q44681568 | Acute rejection and graft survival in renal transplanted patients with viral diseases. |
| Q43194453 | Acute rejection features in dual kidney transplant recipients from elderly donors: comparison of calcineurin inhibitor-based and calcineurin inhibitor-free immunosuppressive protocols. |
| Q50898220 | Alefacept combined with tacrolimus, mycophenolate mofetil and steroids in de novo kidney transplantation: a randomized controlled trial. |
| Q43791666 | Alendronate prevents further bone loss in renal transplant recipients. |
| Q44101704 | Antilymphocyte induction is no longer necessary in simultaneous pancreas and kidney transplantation |
| Q69859762 | Are urinary enzymes useful markers of kidney damage in obstructive jaundice? An experimental study on Sprague-Dawley rats |
| Q41046460 | Aromatic and branched chain amino acids after porto-caval anastomosis: plasma and brain regional levels in the rat (author's transl) |
| Q60218588 | Assessment of pretransplantation warm ischemia time by phosphorus-31 magnetic resonance spectroscopy in pig kidneys |
| Q50355997 | Assessment of telephone speech perception in individuals who received cochlear implant in the period 1993-2003. |
| Q60218585 | Biphasic behavior of the kinetics of 31P-containing metabolites in ischemic porcine kidneys |
| Q46554256 | Blood cyclosporine level soon after kidney transplantation is a major determinant of rejection: insights from the Mycophenolate Steroid-Sparing Trial. |
| Q42943616 | C4d-Positive Renal Allograft Rejection Biopsies in Cyclosporine-Treated Patients: Single-Center Incidence and Outcome |
| Q62002770 | Calcimimetic and vitamin D analog use in hemodialyzed patients is associated with increased levels of vitamin K dependent proteins |
| Q41745362 | Cerebral amino acid levels and uptake in rats after portocaval anastomosis : I. Regional studies in vitro |
| Q41745366 | Cerebral amino acid levels and uptake in rats after portocaval anastomosis: II. Regional studies in vivo |
| Q61388025 | Co-administration of sirolimus alters tacrolimus pharmacokinetics in a dose-dependent manner in adult renal transplant recipients |
| Q46345374 | Cobalt protoporpyhrin reduces caspase-3,-7 enzyme activity in neonatal porcine islets, but does not inhibit cell death induced by TNF-alpha |
| Q80783370 | Combined liver and kidney transplantation: analysis of Padova experience |
| Q34594158 | Combined liver-kidney transplantation in a 15-year-old boy with alpha1-antitrypsin deficiency. |
| Q46103441 | Comparison of Cytomegalovirus (CMV) Enzyme-Linked Immunosorbent Spot and CMV Quantiferon Gamma Interferon-Releasing Assays in Assessing Risk of CMV Infection in Kidney Transplant Recipients. |
| Q37036219 | Comparison of cytomegalovirus (CMV) enzyme-linked immunosorbent spot and CMV quantiferon gamma interferon-releasing assays in assessing risk of CMV infection in kidney transplant recipients |
| Q46970385 | Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment |
| Q77740864 | Complications of pancreas transplantation in an initial experience of a transplant programme |
| Q53115811 | Coronary Microvascular Dysfunction Predicts Long-Term Outcome in Simultaneous Pancreas-Kidney Transplantation. |
| Q46428229 | Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation |
| Q73286049 | Cyclosporin-induced endothelial dysfunction and hypertension: are nitric oxide system abnormality and oxidative stress involved? |
| Q41731036 | Desensitization with plasmapheresis and anti-Cd20 for ABO incompatible kidney transplantation from living donor: experience of a single center in Italy |
| Q43660933 | Deuterium nuclear magnetic resonance for evaluating the metabolic status of livers subjected to warm ischemia. |
| Q71097773 | Does liver arterialization improve the altered cerebral amino acid pattern in the rat after portacaval shunt? |
| Q43828565 | Does taking part in multiple clinical studies with new immunosuppressive agents affect the outcome of renal transplantation? |
| Q83311326 | Dual kidney transplantation after liver transplantation: a good option to rescue a patient from dialysis |
| Q58004292 | Early activation of fibrogenesis in transplanted kidneys: A study on serial renal biopsies |
| Q39989561 | Effect of ACTH on the zona reticularis of the rat adrenal cortex: An ultrastructural stereologic study |
| Q73869072 | Effect of L-arginine and oligotide on liver ischemia-reperfusion injury |
| Q70920220 | Effect of L-dopa treatment on cerebral amino acid levels in rats after portocaval anastomosis |
| Q48474489 | Effect of hyperammonemia and methionine sulfoximine on the kinetic parameters of blood-brain transport of leucine and phenylalanine. |
| Q70276252 | Effects of amino acid infusions on liver regeneration after partial hepatectomy in the rat |
| Q67796095 | Effects of defibrotide on renal function and urinary prostanoid excretion in ciclosporin-treated rats |
| Q46765559 | Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year observational results. |
| Q40325148 | Efficacy and safety of tacrolimus compared with ciclosporin-A in renal transplantation: 7-year observational results. |
| Q47577281 | Efficacy of Prolonged- and Immediate-release Tacrolimus in Kidney Transplantation: A Pooled Analysis of Two Large, Randomized, Controlled Trials. |
| Q77176468 | Efficacy of SH U 508 A (Levovist) in color Doppler imaging of pancreatic grafts |
| Q40336926 | Epstein-Barr virus-associated gastric carcinoma 33 years after kidney transplantation |
| Q60213345 | Evaluation of Cytomegalovirus (CMV)–Specific T Cell Immune Reconstitution Revealed That Baseline Antiviral Immunity, Prophylaxis, or Preemptive Therapy but not Antithymocyte Globulin Treatment Contribute to CMV‐Specific T Cell Reconstitution in K |
| Q73984167 | Evaluation of liver function and morphology following ischemia-reperfusion injury in pigs |
| Q84028906 | Everolimus and minimization of cyclosporine in renal transplantation: 24-month follow-up of the EVEREST study |
| Q86254871 | Everolimus associated with low-dose calcineurin inhibitors, an option in kidney transplant recipients of very old donors |
| Q67371081 | Experimental problems in portal hypertension |
| Q58004439 | Functional and morphological effects of defibrotide on renal ischemia |
| Q71012393 | Functional evaluation of distal esophagus and lower esophageal sphincter after esophagogastric devascularization, esophageal transection and antireflux procedure for bleeding esophageal varices |
| Q68870470 | Gastrointestinal perforations in renal transplant recipients immunosuppressed with cyclosporin |
| Q58004250 | Glomerular C4d Immunoreactivity in Acute Rejection Biopsies of Renal Transplant Patients |
| Q58004255 | Glomerulitis and endothelial cell enlargement in C4d+ and C4d− acute rejections of renal transplant patients |
| Q36332625 | Headache in kidney transplantation |
| Q43039111 | Hepatitis C virus infection in end stage renal disease and after kidney transplant. |
| Q51234600 | Heterotopic cardiac xenotransplantation in rodents: report of a refined technique in a hamster-to-rat model. |
| Q58004319 | Histological Markers of Humoral Rejection in Renal Transplant Patients |
| Q40162118 | How does age affect the outcome of kidney transplantation in elderly recipients? |
| Q84509969 | Images in clinical medicine. Autosomal dominant polycystic kidney disease |
| Q72538110 | Immunosuppressive effects of defibrotide |
| Q73893086 | Improved fibrinolytic capacity after withdrawal of steroid immunosuppression in renal transplant recipients |
| Q42936230 | In vitro and in vivo immunomodulatory effects of cobalt protoporphyrin administered in combination with immunosuppressive drugs. |
| Q58004358 | Inadvertent cadaver kidney transplantation across the ABO barrier: a case report |
| Q67897779 | Increased renal production of cytochrome P450-dependent metabolites of arachidonic acid in cyclosporine-induced nephrotoxicity |
| Q54388692 | Increased rho-kinase activity in hypertensive patients with left ventricular hypertrophy. |
| Q74414785 | Insulin secretion in IDDM patients who have undergone successful pancreas-kidney transplantation |
| Q81323217 | Ipsilateral placement in double-kidney transplantation: an old technique in a new fashion |
| Q40880643 | Is warm ischemia the main limiting factor in the use of non-heart-beating donors in renal transplantation? |
| Q73984224 | Kidney preservation in pigs using celsior, a new organ preservation solution |
| Q44370551 | Kidney transplant in Gitelman's syndrome. Report of the first case. |
| Q82298696 | Kidney transplantation from anti-HBc+ donors: results from a retrospective Italian study |
| Q80783143 | Laparoscopic live donor nephrectomy: single center experience |
| Q73788804 | Liver-kidney-transplantation in type 1 primary hyperoxaluria: description and comments on a case |
| Q57702760 | Long-Term Outcome of Renal Transplantation from Older Donors |
| Q48160376 | Long-term outcome of renal transplantation from octogenarian donors: A multicenter controlled study. |
| Q47281951 | Methotrexate for immunosuppression in life-supporting pig-to-cynomolgus monkey renal xenotransplantation. |
| Q37457210 | MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma. |
| Q58004341 | Monolateral placement of both kidneys in dual kidney transplantation: low surgical complication rate and short operating time* |
| Q78398488 | Mumps-associated nephritis mimicking acute rejection in a patient under chronic dialysis treatment because of graft dysfunction |
| Q73788810 | Mycophenolate mofetil (MMF) versus azathioprine (AZA) in pancreas transplantation: a single-center experience |
| Q34339763 | Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial |
| Q43421449 | Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial. |
| Q73868891 | Neoral versus Sandimmun in kidney-pancreas transplantation |
| Q68022785 | Non--heart-beating donors: an alternative organ source in kidney transplantation |
| Q83446953 | Nonadherent behaviors after solid organ transplantation |
| Q80223970 | Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection? |
| Q73649216 | Oesophageal and cardia function in patients with paraoesophageal hiatus hernia |
| Q48378608 | Organ donors with small renal cancer: report of 3 cases. |
| Q57702274 | Outcome of Renal Transplantation from Very Old Donors |
| Q73788789 | Oxidative stress and nitric oxide system in post-transplant hypertension |
| Q43552729 | Pancreas preservation with Celsior solution in a pig autotransplantation model: comparative study with University of Wisconsin solution. |
| Q73788795 | Parathyroid hormone and bone metabolism in kidney-transplanted patients |
| Q47409972 | Pathophysiology of Post Transplant Hypertension in Kidney Transplant: Focus on Calcineurin Inhibitors Induced Oxidative Stress and Renal Sodium Retention and Implications with RhoA/Rho Kinase Pathway |
| Q58004345 | Perforin, Granzyme B, and Fas Ligand for Molecular Diagnosis of Acute Renal-Allograft Rejection: Analyses on Serial Biopsies Suggest Methodological Issues |
| Q45100316 | Performance of different prediction equations for estimating renal function in kidney transplantation |
| Q84746483 | Persistent secondary hyperparathyroidism and vertebral fractures in kidney transplantation: role of calcium-sensing receptor polymorphisms and vitamin D deficiency |
| Q43834595 | Persistently increased bone turnover and low bone density in long-term survivors to kidney transplantation. |
| Q35268217 | Physical activity in solid organ transplant recipients: organizational aspects and preliminary results of the Italian project |
| Q58004323 | Plasma exchange in a patient with primary antiphospholipid syndrome undergoing kidney transplantation |
| Q44405392 | Plasma fibrinolytic capacity in renal transplant recipients: effect of steroid-free immunosuppression therapy. |
| Q81975401 | Post-transplant lymphoproliferative disorders after heart or kidney transplantation at a single centre: presentation and response to treatment |
| Q35810035 | Potential clinical implications of substitution of generic cyclosporine formulations for cyclosporine microemulsion (Neoral) in transplant recipients. |
| Q38379448 | Potential role of effector memory T cells in chronic T cell-mediated kidney graft rejection. |
| Q72603003 | Prevention of renal ischemic damage by endothelial protecting agents |
| Q73278100 | Protective effect of L-arginine on liver ischemia-reperfusion injury |
| Q71809452 | Protective effect of superoxide dismutase and polyethylene glycol-linked superoxide dismutase against renal warm ischemia/reperfusion injury |
| Q73669589 | Quality-of-life change after kidney transplantation |
| Q72287885 | Reduced fibrinolytic potential one year after kidney transplantation. Relationship to long-term steroid treatment |
| Q35965432 | Renal transplantation. Strategies to prevent organ rejection--the role of an inter-regional reference center. |
| Q56334541 | Risk of de novo cancers after transplantation: Results from a cohort of 7217 kidney transplant recipients, Italy 1997–2009 |
| Q58004347 | Role of the Pathologist in Organ Transplantation: The North Italy Transplant Program Experience |
| Q46637844 | Secondary hyperparathyroidism is associated with vitamin D receptor polymorphism and bone density after renal transplantation. |
| Q58004400 | Short-term outcome of dual kidney transplantation at a single center |
| Q43178465 | Sotrastaurin, a novel small molecule inhibiting protein kinase C: first clinical results in renal-transplant recipients. |
| Q51698914 | Suicidal inactivation of human cytochrome P-450 by carbon tetrachloride and halothane in vitro. |
| Q51414248 | Swine pancreas preservation with Celsior solution. |
| Q46936587 | Tacrolimus combined with two different dosages of sirolimus in kidney transplantation: results of a multicenter study. |
| Q42907622 | Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study. |
| Q84574178 | Technical aspects of unilateral dual kidney transplantation from expanded criteria donors: experience of 100 patients |
| Q69739262 | The effect of end-to-side portacaval shunt on cyclosporine pharmacokinetics in rats |
| Q53667109 | The era of the new directly acting antivirals: Has the time come for kidney transplant only in compensated cirrhosis? |
| Q74295915 | The protective effects of L-arginine after liver ischaemia/reperfusion injury in a pig model |
| Q47305243 | Therapeutic apheresis in kidney AB0 incompatible transplantation. |
| Q79967856 | Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant |
| Q33293885 | Topical photodynamic therapy of actinic keratosis in renal transplant recipients. |
| Q58004447 | Transplantation of Warm Ischemia Damaged Kidneys: An Experimental Study in Pigs |
| Q44985286 | Transplantation: Optimizing outcomes in elderly kidney transplant recipients. |
| Q82686544 | Transplantation: can a single criterion determine the use of ECD kidneys? |
| Q67906310 | Treatment of lymphocele following renal transplantation by laparoscopic surgery |
| Q71711325 | Two cases of Kaposi's sarcoma in renal and liver transplant recipients treated with interferon |
| Q72670610 | UW vs Euro-Collins solution in preserving warm ischemia-damaged kidneys |
| Q40409705 | Use of a BJAB-derived cell line for isolation of human herpesvirus 8 |
| Q69697755 | [Cyclosporin] |
| Q69932881 | [Etching of the enamel with pyruvic acid. For much more surface] |
| Q67453975 | [In vivo aminoacid transport in the brain of the rat with porto-caval anastomosis (author's transl)] |
| Q84325526 | [Living donor kidney transplant: the surgical procedure] |
| Q81565127 | [Renal transplantation in the North Italy Transplant program (NITp): Organ allocation and results] |
| Q54326337 | [Renal transplantation. 1st year's experience at a new center]. |
| Q95451273 | [Surgical overview on kidney and pancreas transplantation] |
| Q84913414 | [The debate on preemptive transplantation: queries and limits] |
| Q77176628 | ecNOS overexpression in CsA-treated renal transplant patients: implications for CsA-induced hypertension |
Search more.